Product Description
Toradol USP ≥98.5% API Pharmaceutical made in china 74103-07-4
AI Product Description
*The following content is generated by AI and is for reference only.
Toradol, chemically known as ketorolac tromethamine, is a potent non-steroidal anti-inflammatory drug (NSAID) widely recognized for its efficacy in managing moderate to severe acute pain. The active pharmaceutical ingredient (API), specified here with a purity of ≥98.5%, is manufactured in China under strict United States Pharmacopeia (USP) standards to ensure high quality and consistency. This specific grade of Toradol USP API serves as the foundational component for various pharmaceutical formulations, including injectable solutions, tablets, and ophthalmic drops, tailored for clinical settings ranging from post-surgical recovery to trauma management.
The molecular formula of ketorolac tromethamine is C15H20N2O6, reflecting its complex structure designed to inhibit cyclooxygenase enzymes effectively. Its corresponding CAS number is 74103-07-8, a unique identifier essential for regulatory compliance, inventory tracking, and scientific research globally. As a non-opioid analgesic, Toradol offers significant pain relief without the risk of respiratory depression or addiction associated with narcotics, making it a preferred choice for short-term treatment strategies. It is particularly valuable in hospital environments where rapid onset of action is critical for patient comfort following procedures such as orthopedic surgeries, dental extractions, or renal colic episodes.
Manufactured in China, this high-purity API adheres to rigorous international quality control protocols, ensuring that the final products meet the stringent safety and efficacy requirements of major markets like the United States and Europe. The ≥98.5% purity guarantee minimizes impurities, thereby reducing the potential for adverse reactions and enhancing therapeutic reliability. Pharmaceutical companies sourcing this material benefit from its robust stability profile and cost-effectiveness, which supports large-scale production of generic and branded medications. Beyond acute pain management, ongoing research explores its potential applications in inflammatory conditions, although its use is generally restricted to short durations due to gastrointestinal and renal risks associated with prolonged NSAID therapy. Ultimately, Toradol USP API represents a cornerstone in modern pain management protocols, bridging the gap between mild discomfort and severe surgical pain with precision and safety.